2-[3-[[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-15-(2-amino-2-oxoethyl)-27-[(2-amino-2-oxoethyl)carbamoyl]-33,36-dibutyl-42-[2-(heptylcarbamoylamino)ethyl]-6-[(heptylcarbamoylamino)methyl]-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-(1H-indol-3-ylmethyl)-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-39-yl]methyl]indol-1-yl]acetic acid

C107H161N23O23S — CID 164841027

IUPAC2-[3-[[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-15-(2-amino-2-oxoethyl)-27-[(2-amino-2-oxoethyl)carbamoyl]-33,36-dibutyl-42-[2-(heptylcarbamoylamino)ethyl]-6-[(heptylcarbamoylamino)methyl]-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-(1H-indol-3-ylmethyl)-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-39-yl]methyl]indol-1-yl]acetic acid
SMILESCCCCCCCNC(=O)NCC[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CNC(=O)NCCCCCCC)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCC)N(C)C(=O)[C@H](CCCC)N(C)C(=O)[C@H](Cc2cn(CC(=O)O)c3ccccc23)NC1=O
InChIInChI=1S/C107H161N23O23S/c1-13-17-21-23-29-44-110-106(152)112-46-43-74-94(140)122-79(52-68-58-128(60-91(136)137)83-37-28-26-33-72(68)83)102(148)127(12)86(36-20-16-4)105(151)126(11)84(35-19-15-3)98(144)118-75(48-63(5)6)95(141)124-82(93(139)114-57-89(109)134)61-154-62-90(135)116-78(50-66-39-41-69(131)42-40-66)101(147)125(10)65(9)92(138)120-80(54-88(108)133)103(149)129-47-31-38-85(129)99(145)123-81(56-115-107(153)111-45-30-24-22-18-14-2)97(143)121-77(49-64(7)8)104(150)130-59-70(132)53-87(130)100(146)119-76(96(142)117-74)51-67-55-113-73-34-27-25-32-71(67)73/h25-28,32-34,37,39-42,55,58,63-65,70,74-82,84-87,113,131-132H,13-24,29-31,35-36,38,43-54,56-57,59-62H2,1-12H3,(H2,108,133)(H2,109,134)(H,114,139)(H,116,135)(H,117,142)(H,118,144)(H,119,146)(H,120,138)(H,121,143)(H,122,140)(H,123,145)(H,124,141)(H,136,137)(H2,110,112,152)(H2,111,115,153)/t65-,70+,74-,75-,76-,77-,78-,79-,80-,81-,82-,84-,85-,86-,87-/m0/s1
InChIKeyCTCKUXTUIGDCCI-RCOHZGJJSA-N
MW2169.67 g/mol
LogP2.38
Rot. Bonds40

About 2-[3-[[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-15-(2-amino-2-oxoethyl)-27-[(2-amino-2-oxoethyl)carbamoyl]-33,36-dibutyl-42-[2-(heptylcarbamoylamino)ethyl]-6-[(heptylcarbamoylamino)methyl]-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-(1H-indol-3-ylmethyl)-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-39-yl]methyl]indol-1-yl]acetic acid

2-[3-[[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-15-(2-amino-2-oxoethyl)-27-[(2-amino-2-oxoethyl)carbamoyl]-33,36-dibutyl-42-[2-(heptylcarbamoylamino)ethyl]-6-[(heptylcarbamoylamino)methyl]-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-(1H-indol-3-ylmethyl)-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-39-yl]methyl]indol-1-yl]acetic acid (PubChem CID 164841027) has the molecular formula C107H161N23O23S and a molecular weight of 2169.67 g/mol. Its IUPAC name is 2-[3-[[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-15-(2-amino-2-oxoethyl)-27-[(2-amino-2-oxoethyl)carbamoyl]-33,36-dibutyl-42-[2-(heptylcarbamoylamino)ethyl]-6-[(heptylcarbamoylamino)methyl]-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-(1H-indol-3-ylmethyl)-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-39-yl]methyl]indol-1-yl]acetic acid.

Molecular Properties

Compound Name2-[3-[[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-15-(2-amino-2-oxoethyl)-27-[(2-amino-2-oxoethyl)carbamoyl]-33,36-dibutyl-42-[2-(heptylcarbamoylamino)ethyl]-6-[(heptylcarbamoylamino)methyl]-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-(1H-indol-3-ylmethyl)-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-39-yl]methyl]indol-1-yl]acetic acid
PubChem CID164841027
Molecular FormulaC107H161N23O23S
Molecular Weight2169.67 g/mol
Exact Mass2168.19
IUPAC Name2-[3-[[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-15-(2-amino-2-oxoethyl)-27-[(2-amino-2-oxoethyl)carbamoyl]-33,36-dibutyl-42-[2-(heptylcarbamoylamino)ethyl]-6-[(heptylcarbamoylamino)methyl]-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-(1H-indol-3-ylmethyl)-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-39-yl]methyl]indol-1-yl]acetic acid
SMILESCCCCCCCNC(=O)NCC[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CNC(=O)NCCCCCCC)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCC)N(C)C(=O)[C@H](CCCC)N(C)C(=O)[C@H](Cc2cn(CC(=O)O)c3ccccc23)NC1=O
InChIInChI=1S/C107H161N23O23S/c1-13-17-21-23-29-44-110-106(152)112-46-43-74-94(140)122-79(52-68-58-128(60-91(136)137)83-37-28-26-33-72(68)83)102(148)127(12)86(36-20-16-4)105(151)126(11)84(35-19-15-3)98(144)118-75(48-63(5)6)95(141)124-82(93(139)114-57-89(109)134)61-154-62-90(135)116-78(50-66-39-41-69(131)42-40-66)101(147)125(10)65(9)92(138)120-80(54-88(108)133)103(149)129-47-31-38-85(129)99(145)123-81(56-115-107(153)111-45-30-24-22-18-14-2)97(143)121-77(49-64(7)8)104(150)130-59-70(132)53-87(130)100(146)119-76(96(142)117-74)51-67-55-113-73-34-27-25-32-71(67)73/h25-28,32-34,37,39-42,55,58,63-65,70,74-82,84-87,113,131-132H,13-24,29-31,35-36,38,43-54,56-57,59-62H2,1-12H3,(H2,108,133)(H2,109,134)(H,114,139)(H,116,135)(H,117,142)(H,118,144)(H,119,146)(H,120,138)(H,121,143)(H,122,140)(H,123,145)(H,124,141)(H,136,137)(H2,110,112,152)(H2,111,115,153)/t65-,70+,74-,75-,76-,77-,78-,79-,80-,81-,82-,84-,85-,86-,87-/m0/s1
InChIKeyCTCKUXTUIGDCCI-RCOHZGJJSA-N
XLogP2.38
TPSA659.47 Ų
H-Bond Donors20
H-Bond Acceptors24
Rotatable Bonds40
Heavy Atoms154
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002169.67
LogP ≤ 52.38
H-Bond Donors ≤ 520
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-[3-[[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-15-(2-amino-2-oxoethyl)-27-[(2-amino-2-oxoethyl)carbamoyl]-33,36-dibutyl-42-[2-(heptylcarbamoylamino)ethyl]-6-[(heptylcarbamoylamino)methyl]-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-(1H-indol-3-ylmethyl)-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-39-yl]methyl]indol-1-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[3-[[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-15-(2-amino-2-oxoethyl)-27-[(2-amino-2-oxoethyl)carbamoyl]-33,36-dibutyl-42-[2-(heptylcarbamoylamino)ethyl]-6-[(heptylcarbamoylamino)methyl]-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-(1H-indol-3-ylmethyl)-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-39-yl]methyl]indol-1-yl]acetic acid?
The IUPAC name of 2-[3-[[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-15-(2-amino-2-oxoethyl)-27-[(2-amino-2-oxoethyl)carbamoyl]-33,36-dibutyl-42-[2-(heptylcarbamoylamino)ethyl]-6-[(heptylcarbamoylamino)methyl]-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-(1H-indol-3-ylmethyl)-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-39-yl]methyl]indol-1-yl]acetic acid (CID 164841027) is 2-[3-[[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-15-(2-amino-2-oxoethyl)-27-[(2-amino-2-oxoethyl)carbamoyl]-33,36-dibutyl-42-[2-(heptylcarbamoylamino)ethyl]-6-[(heptylcarbamoylamino)methyl]-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-(1H-indol-3-ylmethyl)-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-39-yl]methyl]indol-1-yl]acetic acid.
What is the SMILES notation for 2-[3-[[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-15-(2-amino-2-oxoethyl)-27-[(2-amino-2-oxoethyl)carbamoyl]-33,36-dibutyl-42-[2-(heptylcarbamoylamino)ethyl]-6-[(heptylcarbamoylamino)methyl]-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-(1H-indol-3-ylmethyl)-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-39-yl]methyl]indol-1-yl]acetic acid?
The canonical SMILES for 2-[3-[[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-15-(2-amino-2-oxoethyl)-27-[(2-amino-2-oxoethyl)carbamoyl]-33,36-dibutyl-42-[2-(heptylcarbamoylamino)ethyl]-6-[(heptylcarbamoylamino)methyl]-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-(1H-indol-3-ylmethyl)-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-39-yl]methyl]indol-1-yl]acetic acid is CCCCCCCNC(=O)NCC[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CNC(=O)NCCCCCCC)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCC)N(C)C(=O)[C@H](CCCC)N(C)C(=O)[C@H](Cc2cn(CC(=O)O)c3ccccc23)NC1=O.
What is the InChIKey of 2-[3-[[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-15-(2-amino-2-oxoethyl)-27-[(2-amino-2-oxoethyl)carbamoyl]-33,36-dibutyl-42-[2-(heptylcarbamoylamino)ethyl]-6-[(heptylcarbamoylamino)methyl]-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-(1H-indol-3-ylmethyl)-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-39-yl]methyl]indol-1-yl]acetic acid?
The InChIKey is CTCKUXTUIGDCCI-RCOHZGJJSA-N. The full InChI is InChI=1S/C107H161N23O23S/c1-13-17-21-23-29-44-110-106(152)112-46-43-74-94(140)122-79(52-68-58-128(60-91(136)137)83-37-28-26-33-72(68)83)102(148)127(12)86(36-20-16-4)105(151)126(11)84(35-19-15-3)98(144)118-75(48-63(5)6)95(141)124-82(93(139)114-57-89(109)134)61-154-62-90(135)116-78(50-66-39-41-69(131)42-40-66)101(147)125(10)65(9)92(138)120-80(54-88(108)133)103(149)129-47-31-38-85(129)99(145)123-81(56-115-107(153)111-45-30-24-22-18-14-2)97(143)121-77(49-64(7)8)104(150)130-59-70(132)53-87(130)100(146)119-76(96(142)117-74)51-67-55-113-73-34-27-25-32-71(67)73/h25-28,32-34,37,39-42,55,58,63-65,70,74-82,84-87,113,131-132H,13-24,29-31,35-36,38,43-54,56-57,59-62H2,1-12H3,(H2,108,133)(H2,109,134)(H,114,139)(H,116,135)(H,117,142)(H,118,144)(H,119,146)(H,120,138)(H,121,143)(H,122,140)(H,123,145)(H,124,141)(H,136,137)(H2,110,112,152)(H2,111,115,153)/t65-,70+,74-,75-,76-,77-,78-,79-,80-,81-,82-,84-,85-,86-,87-/m0/s1.
What are the key properties of 2-[3-[[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-15-(2-amino-2-oxoethyl)-27-[(2-amino-2-oxoethyl)carbamoyl]-33,36-dibutyl-42-[2-(heptylcarbamoylamino)ethyl]-6-[(heptylcarbamoylamino)methyl]-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-(1H-indol-3-ylmethyl)-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-39-yl]methyl]indol-1-yl]acetic acid?
2-[3-[[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-15-(2-amino-2-oxoethyl)-27-[(2-amino-2-oxoethyl)carbamoyl]-33,36-dibutyl-42-[2-(heptylcarbamoylamino)ethyl]-6-[(heptylcarbamoylamino)methyl]-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-(1H-indol-3-ylmethyl)-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-39-yl]methyl]indol-1-yl]acetic acid has a molecular weight of 2169.67 g/mol, XLogP of 2.38, 40 rotatable bonds, 20 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-15-(2-amino-2-oxoethyl)-27-[(2-amino-2-oxoethyl)carbamoyl]-33,36-dibutyl-42-[2-(heptylcarbamoylamino)ethyl]-6-[(heptylcarbamoylamino)methyl]-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-(1H-indol-3-ylmethyl)-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-39-yl]methyl]indol-1-yl]acetic acid is sourced from PubChem (CID 164841027), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).